Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 6
2006 3
2007 7
2008 1
2009 3
2010 3
2011 7
2012 7
2013 8
2014 4
2015 8
2016 2
2017 4
2018 3
2019 4
2020 2
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21778168

65 results
Results by year
Filters applied: . Clear all
Page 1
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma.
Girard N, Sima CS, Jackman DM, Sequist LV, Chen H, Yang JC, Ji H, Waltman B, Rosell R, Taron M, Zakowski MF, Ladanyi M, Riely G, Pao W. Girard N, et al. Eur Respir J. 2012 Feb;39(2):366-72. doi: 10.1183/09031936.00010111. Epub 2011 Jul 20. Eur Respir J. 2012. PMID: 21778168 Free article.
Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
Chou TY, Chiu CH, Li LH, Hsiao CY, Tzen CY, Chang KT, Chen YM, Perng RP, Tsai SF, Tsai CM. Chou TY, et al. Clin Cancer Res. 2005 May 15;11(10):3750-7. doi: 10.1158/1078-0432.CCR-04-1981. Clin Cancer Res. 2005. PMID: 15897572 Free article.
EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC, Chae MH, Lee MH, Kim KM, Lee EB, Kim CH, Park TI, Han SB, Jheon S, Jung TH, Park JY. Bae NC, et al. Cancer Genet Cytogenet. 2007 Mar;173(2):107-13. doi: 10.1016/j.cancergencyto.2006.10.007. Cancer Genet Cytogenet. 2007. PMID: 17321325
Epidermal growth factor receptor double activating mutations involving both exons 19 and 21 exist in Chinese non-small cell lung cancer patients.
Zhang GC, Lin JY, Wang Z, Zhou Q, Xu CR, Zhu JQ, Wang K, Yang XN, Chen G, Yang JJ, Huang YJ, Liao RQ, Wu YL. Zhang GC, et al. Clin Oncol (R Coll Radiol). 2007 Sep;19(7):499-506. doi: 10.1016/j.clon.2007.04.006. Epub 2007 May 29. Clin Oncol (R Coll Radiol). 2007. PMID: 17537621
EGFR mutations are associated with prognosis but not with the response to front-line chemotherapy in the Chinese patients with advanced non-small cell lung cancer.
Wu M, Zhao J, Song SW, Zhuo M, Wang X, Bai H, Wang S, Yang L, An T, Zhang Y, Duan J, Wang Y, Guo Q, Liu X, Liu N, Wang J. Wu M, et al. Lung Cancer. 2010 Mar;67(3):343-7. doi: 10.1016/j.lungcan.2009.04.011. Epub 2009 May 27. Lung Cancer. 2010. PMID: 19477549
Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
Sakuma Y, Matsukuma S, Yoshihara M, Nakamura Y, Noda K, Nakayama H, Kameda Y, Tsuchiya E, Miyagi Y. Sakuma Y, et al. Am J Clin Pathol. 2007 Jul;128(1):100-8. doi: 10.1309/WVXFGAFLAUX48DU6. Am J Clin Pathol. 2007. PMID: 17580276
Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features.
Tam IY, Chung LP, Suen WS, Wang E, Wong MC, Ho KK, Lam WK, Chiu SW, Girard L, Minna JD, Gazdar AF, Wong MP. Tam IY, et al. Clin Cancer Res. 2006 Mar 1;12(5):1647-53. doi: 10.1158/1078-0432.CCR-05-1981. Clin Cancer Res. 2006. PMID: 16533793 Free article.
Molecular diagnostic algorithm for epidermal growth factor receptor mutation detection in Asian lung adenocarcinomas: comprehensive analyses of 445 Taiwanese patients with immunohistochemistry, PCR-direct sequencing and Scorpion/ARMS methods.
Ho HL, Chang FP, Ma HH, Liao LR, Chuang YT, Chang-Chien YC, Lin KY, Chou TY. Ho HL, et al. Respirology. 2013 Nov;18(8):1261-70. doi: 10.1111/resp.12148. Respirology. 2013. PMID: 23796143
65 results
Jump to page